CMS-0062: Latest Developments on Electronic Data Interchange and Drug Prior Authorization
CMS-0062 Information - Workgroup for Electronic Data Interchange (WEDI)
Summary
The Centers for Medicare & Medicaid Services (CMS) proposed expanding electronic prior authorization (ePA) requirements using FHIR-based APIs to include drug information, advancing data sharing between patients and providers. This aims to reduce administrative burden and accelerate access to necessary treatments.
Details
The CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062) seeks to expand electronic prior authorization (ePA) requirements from medical services/items into the drug domain. The proposal mandates the use of standardized, Fast Healthcare Interoperability Resources® (FHIR®)-based APIs, requiring payers to support ePA for drugs. It also aims for shorter decision timeframes and greater transparency in denial rates. A central technical component is the update of multiple HL7 FHIR Implementation Guides (IGs), including Da Vinci modules like Coverage Requirements Discovery (CRD), Documentation Templates and Rules (DTR), Prior Authorization Support (PAS), and Payer Data Exchange (PDex). These updates replace previous versions, aiming to automate data exchange and improve standardization across the healthcare ecosystem. Collectively, these provisions build upon ONC's interoperability efforts by standardizing how patient, provider, and payer data are exchanged. The goal is to replace manual, fragmented processes with efficient, standardized workflows, thereby improving care coordination and accelerating patient access to medically necessary therapies. These new standards are effective as of October 1, 2026.
Original content copyright by respective publishers